Effect of erythromycin on mortality and the host response in critically ill patients with sepsis

Original language	English
Article number	151
Pages (from-to)	151
Journal	Critical care (London, England)
Volume	26
Issue number	1
DOIs	https://doi.org/10.1186/s13054-022-04016-x
Publication status	Published - Dec 2022

Critically ill, Erythromycin, Immunomodulation, Macrolides, Mortality, Propensity score, Sepsis, Target trial

ID: 23976258

Generic Portal